I9898
Anti-Interleukin-5 antibody produced in goat
IgG fraction of antiserum, lyophilized powder
Sinónimos:
Anti-IL-5
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
conjugado:
unconjugated
application:
ELISA (i)
Neutral
WB
Neutral
WB
clon:
polyclonal
reactividad de especies:
human
citations:
3
técnicas:
indirect ELISA: 0.5-1.0 μg/test
neutralization: suitable
western blot: 1-2 μg/mL
neutralization: suitable
western blot: 1-2 μg/mL
origen biológico
goat
Nivel de calidad
conjugado
unconjugated
forma del anticuerpo
IgG fraction of antiserum
tipo de anticuerpo
primary antibodies
clon
polyclonal
Formulario
lyophilized powder
reactividad de especies
human
técnicas
indirect ELISA: 0.5-1.0 μg/test
neutralization: suitable
western blot: 1-2 μg/mL
Nº de acceso UniProt
temp. de almacenamiento
−20°C
modificación del objetivo postraduccional
unmodified
Información sobre el gen
human ... IL5(3567)
Descripción general
The antibody neutralizes the biological activity of recombinant human IL-5.
Inmunógeno
recombinant human IL expressed in Sf 21 insect cell line.
Acciones bioquímicas o fisiológicas
Interleukin-5 is a T-cell derived cytokine that induces the differentiation of B cells into antibody producing plasma cells. It is a critical differentiation factor for eosinophils and regulates the expression of genes required for cell proliferation, survival and maturation. The cellular functions of IL-5 are mediated by JAK-STAT, Btk and Ras/Raf-ERK signaling pathways. IL-5 is a good molecular target for the treatment of eosinophilic diseases.
Forma física
Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline.
Nota de preparación
Purified using protein G.
¿No encuentra el producto adecuado?
Pruebe nuestro Herramienta de selección de productos.
Código de clase de almacenamiento
11 - Combustible Solids
Clase de riesgo para el agua (WGK)
WGK 2
Punto de inflamabilidad (°F)
Not applicable
Punto de inflamabilidad (°C)
Not applicable
Equipo de protección personal
Eyeshields, Gloves, type N95 (US)
Elija entre una de las versiones más recientes:
Certificados de análisis (COA)
Lot/Batch Number
¿No ve la versión correcta?
Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Taku Kouro et al.
International immunology, 21(12), 1303-1309 (2009-10-13)
IL-5 was originally defined as a T-cell-derived cytokine that triggers activated B cells for terminal differentiation into antibody-secreting plasma cells, at least in mice. Concurrently, IL-5 was recognized as the major maturation and differentiation factor for eosinophils in mice and
Kiyoshi Takatsu
Proceedings of the Japan Academy. Series B, Physical and biological sciences, 87(8), 463-485 (2011-10-12)
While interleukin-5 (IL-5) is initially identified by its ability to support the growth and terminal differentiation of mouse B cells in vitro into antibody-secreting cells, recombinant IL-5 exerts pleiotropic activities on various target cells including B cells, eosinophils, and basophils.
Jonathan Corren
Discovery medicine, 13(71), 305-312 (2012-05-01)
Elevated numbers of blood and tissue eosinophils are present in allergic diseases and experimental evidence suggests that eosinophils play an important pathogenic role in these conditions. Regulation of eosinophil maturation, recruitment, and survival is under the control of a small
Patricia C Fulkerson et al.
Journal of immunology (Baltimore, Md. : 1950), 193(8), 4043-4052 (2014-09-19)
Eosinophils originate in the bone marrow from an eosinophil lineage-committed, IL-5Rα-positive, hematopoietic progenitor (eosinophil progenitor). Indeed, IL-5 is recognized as a critical regulator of eosinophilia and has effects on eosinophil progenitors, eosinophil precursors, and mature eosinophils. However, substantial levels of
Qiong Long et al.
Human vaccines & immunotherapeutics, 10(8), 2303-2311 (2014-11-27)
We sought to develop an IL-33 vaccine and evaluate its efficacy in a mouse model of asthma. The full-length molecules of putative mature IL-33 were inserted into the immunodominant epitope region of hepatitis B core antigen using gene recombination techniques.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico